Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

GABRQ (Q9UN88) - Domains And Structures - Molecular Target Synopsis

Click Here to View Molecular Target 3D Synopsis

Select a homology cutoff:
Structural Sequence Similarity Matches
Domains Covered Gene Name (Uniprot) Solved in Complex with Organism PDB Chain Identity E-Value Resolution Ligands Release Date
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUP_A 37.33 3.0E-52 3.58Å NAG BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) HUMAN 6HUJ_C 38.72 4.0E-57 3.04Å NAG 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) RAT 6DW1_A 37.33 7.0E-52 3.1Å NAG ABU BMA MAN 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) HUMAN 6D6T_A 52.32 1.0E-94 3.8Å Y01 NAG ABU BMA 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE 6HUG_D 37.33 3.0E-52 3.1Å NAG BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) HUMAN 6HUK_C 38.72 4.0E-57 3.69Å NAG 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) HUMAN 6D6U_B 37.33 5.0E-52 3.8Å Y01 NAG BMA MAN 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAF_A 41.2 1.0E-61 3.8Å NAG IVM 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUO_B 51.99 5.0E-94 3.26Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDI_B 41.69 1.0E-61 3.08Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUP_E 51.99 5.0E-94 3.58Å NAG ABU BMA MAN DZP 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIO_C 41.69 2.0E-61 3.25Å NAG 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIN_B 41.69 1.0E-61 2.61Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDI_A 41.69 1.0E-61 3.08Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) RAT 6DW1_B 51.58 2.0E-94 3.1Å NAG BMA 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA1 (P23415) - 2M6I_B 50 2.0E-17 - 2013-09-04
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDI_E 41.69 1.0E-61 3.08Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIO_A 41.69 2.0E-61 3.25Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) HUMAN 6D6U_C 52.32 1.0E-94 3.8Å Y01 NAG ABU BMA 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5OJM_D 47.49 2.0E-79 3.3Å NAG BMA MAN 2017-10-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAE_A 41.2 1.0E-61 3.9Å NAG 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAE_B 41.2 1.0E-61 3.9Å NAG 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867) HUMAN 6I53_B 51.99 5.0E-94 3.2Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIO_B 41.69 2.0E-61 3.25Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUK_B 51.99 5.0E-94 3.69Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE 6HUG_A 37.33 3.0E-52 3.1Å NAG BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRB3 (P28472) HUMAN 6I53_C 38.72 4.0E-57 3.2Å NAG 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA1 (P23415) - 2M6I_C 50 2.0E-17 - 2013-09-04
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDH_B 41.69 2.0E-61 2.85Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA1 (P23415) - 2M6B_A 50 2.0E-17 - 2013-09-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAE_E 41.2 1.0E-61 3.9Å NAG 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) HUMAN 6A96_D 52.32 6.0E-94 3.51Å NAG BMA MAN 2018-10-03
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5O8F_E 47.49 3.0E-79 3.19Å NAG BMA MAN P9N 2017-11-01
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) HUMAN 6A96_C 52.32 6.0E-94 3.51Å NAG BMA MAN 2018-10-03
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5CFB_E 41.69 2.0E-61 3Å NAG SY9 2015-09-30
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867) GABRG2 (P18507), GABRB3 (P28472) HUMAN 6I53_D 37.33 3.0E-52 3.2Å NAG POV BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867) HUMAN 6I53_E 51.99 5.0E-94 3.2Å NAG POV BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) RAT 6DW1_E 51.58 2.0E-94 3.1Å NAG BMA 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA1 (P23415) - 2M6I_A 50 2.0E-17 - 2013-09-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) - HUMAN 4COF_E 52.32 4.0E-94 2.97Å NAG BMA BEN 2014-06-04
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIN_A 41.69 1.0E-61 2.61Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) HUMAN 6D6U_A 52.32 1.0E-94 3.8Å Y01 NAG ABU BMA 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRG2 (P18507) GABRB2 (P47870), GABRA1 (P14867) HUMAN 6D6U_E 38.67 4.0E-57 3.8Å Y01 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUK_D 37.33 3.0E-52 3.69Å NAG BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P08219) HUMAN 6HUG_E 51.99 5.0E-94 3.1Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) HUMAN 6A96_B 52.32 6.0E-94 3.51Å NAG ABU BMA MAN 2018-10-03
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644) GABRB3 (P28472) HUMAN 6A96_A 35.4 4.0E-51 3.51Å NAG BMA MAN 2018-10-03
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUJ_D 37.33 3.0E-52 3.04Å NAG ABU BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUP_B 51.99 5.0E-94 3.58Å NAG ABU BMA MAN DZP 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) HUMAN 6D6T_B 37.33 5.0E-52 3.8Å Y01 NAG BMA MAN 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDH_A 41.69 2.0E-61 2.85Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA1 (P23415) - 2M6I_D 50 2.0E-17 - 2013-09-04
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIO_E 41.69 2.0E-61 3.25Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabrg2 (P18508) Gabrb1 (P15431), Gabra1 (P62813) RAT 6DW1_D 38.72 3.0E-57 3.1Å - 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUO_D 37.33 3.0E-52 3.26Å 08H NAG BMA PIO MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) HUMAN 6D6U_D 37.33 5.0E-52 3.8Å Y01 FYP NAG BMA MAN 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) RAT 6DW0_B 51.58 2.0E-94 3.8Å NAG ABU BMA 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAE_D 41.2 1.0E-61 3.9Å NAG 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5O8F_D 47.49 3.0E-79 3.19Å NAG BMA MAN P9N 2017-11-01
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIN_E 41.69 1.0E-61 2.61Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAD_C 41.2 1.0E-61 3.9Å NAG SY9 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5OJM_C 47.49 2.0E-79 3.3Å NAG BMA MAN 2017-10-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5OJM_E 47.49 2.0E-79 3.3Å NAG BMA MAN 2017-10-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAD_D 41.2 1.0E-61 3.9Å NAG SY9 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) RAT 6DW1_C 37.33 7.0E-52 3.1Å NAG ABU BMA MAN 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5CFB_B 41.69 2.0E-61 3Å NAG SY9 2015-09-30
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabrg2 (P18508) Gabrb1 (P15431), Gabra1 (P62813) RAT 6DW0_D 38.72 3.0E-57 3.8Å - 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUK_E 51.99 5.0E-94 3.69Å NAG H0Z BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAD_E 41.2 1.0E-61 3.9Å NAG SY9 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIO_D 41.69 2.0E-61 3.25Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabrb1 (P15431) Gabra1 (P62813), Gabrg2 (P18508) RAT 6DW0_E 51.58 2.0E-94 3.8Å NAG BMA 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAD_B 41.2 1.0E-61 3.9Å NAG SY9 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (3%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA1 (P23415) - 2M6I_E 50 2.0E-17 - 2013-09-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) HUMAN 6HUO_C 38.72 4.0E-57 3.26Å NAG 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDH_C 41.69 2.0E-61 2.85Å NAG IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIN_D 41.69 1.0E-61 2.61Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRG2 (P18507) GABRA1 (P14867), GABRA1 (P08219), GABRB3 (P28472) HUMAN 6HUP_C 38.72 4.0E-57 3.58Å NAG 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) - HUMAN 4COF_D 52.32 4.0E-94 2.97Å NAG BMA BEN 2014-06-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAF_E 41.2 1.0E-61 3.8Å NAG IVM 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5CFB_A 41.69 2.0E-61 3Å NAG SY9 2015-09-30
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDH_D 41.69 2.0E-61 2.85Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) RAT 6DW0_A 37.33 7.0E-52 3.8Å NAG ABU BMA MAN 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867) GABRG2 (P18507), GABRB3 (P28472) HUMAN 6I53_A 37.33 3.0E-52 3.2Å NAG POV BMA MAN PIO 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDH_E 41.69 2.0E-61 2.85Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) - HUMAN 4COF_A 52.32 4.0E-94 2.97Å NAG BMA BEN 2014-06-04
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5CFB_C 41.69 2.0E-61 3Å NAG SY9 2015-09-30
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRA5 (P31644) HUMAN 6A96_E 52.32 6.0E-94 3.51Å NAG BMA MAN 2018-10-03
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAD_A 41.2 1.0E-61 3.9Å NAG SY9 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUP_D 37.33 3.0E-52 3.58Å NAG BMA PIO MAN DZP 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5OJM_B 47.49 2.0E-79 3.3Å NAG BMA MAN 2017-10-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAF_B 41.2 1.0E-61 3.8Å NAG IVM 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUO_E 51.99 5.0E-94 3.26Å NAG ABU BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUK_A 37.33 3.0E-52 3.69Å NAG H0Z BMA PIO MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDI_C 41.69 1.0E-61 3.08Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5O8F_B 47.49 3.0E-79 3.19Å NAG BMA MAN P9N 2017-11-01
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB2 (P47870) GABRG2 (P18507), GABRA1 (P14867) HUMAN 6D6T_C 52.32 1.0E-94 3.8Å NAG ABU BMA 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAF_D 41.2 1.0E-61 3.8Å NAG IVM 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (16%) (view alignment) GABRG2 (P18507) GABRB2 (P47870), GABRA1 (P14867) HUMAN 6D6T_E 38.64 4.0E-53 3.8Å NAG 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUJ_B 51.99 5.0E-94 3.04Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5CFB_D 41.69 2.0E-61 3Å NAG SY9 2015-09-30
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAE_C 41.2 1.0E-61 3.9Å NAG 2015-09-09
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUJ_A 37.33 3.0E-52 3.04Å NAG ABU BMA MAN PIO RI5 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) - HUMAN 4COF_B 52.32 4.0E-94 2.97Å NAG BMA BEN 2014-06-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRG2 (P18507) GABRA1 (P08219), GABRB3 (P28472) HUMAN 6HUG_C 38.72 4.0E-57 3.1Å NAG RI5 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5TIN_C 41.69 1.0E-61 2.61Å 7C6 2017-01-18
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) - HUMAN 4COF_C 52.32 4.0E-94 2.97Å NAG BMA BEN 2014-06-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867), GABRA1 (P08219) GABRG2 (P18507), GABRB3 (P28472) BOVINE, HUMAN 6HUO_A 37.33 3.0E-52 3.26Å NAG ABU BMA PIO MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) Gabra1 (P62813) Gabrb1 (P15431), Gabrg2 (P18508) RAT 6DW0_C 37.33 7.0E-52 3.8Å NAG BMA MAN 2018-08-08
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5OJM_A 47.49 2.0E-79 3.3Å NAG BMA MAN 2017-10-04
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5O8F_A 47.49 3.0E-79 3.19Å NAG BMA MAN 2017-11-01
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA1 (P14867) GABRB2 (P47870), GABRG2 (P18507) HUMAN 6D6T_D 37.33 5.0E-52 3.8Å Y01 FYP NAG BMA MAN 2018-06-27
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GABRA5 (P31644), GABRB3 (P28472) - HUMAN 5O8F_C 47.49 3.0E-79 3.19Å NAG BMA MAN P9N 2017-11-01
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P14867), GABRA1 (P08219) HUMAN 6HUJ_E 51.99 5.0E-94 3.04Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (99%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) GLRA3 (O75311) - HUMAN 5VDI_D 41.69 1.0E-61 3.08Å IVM 7C6 2017-05-24
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (28%) (view alignment) GABRB3 (P28472) GABRG2 (P18507), GABRA1 (P08219) HUMAN 6HUG_B 51.99 5.0E-94 3.1Å NAG BMA MAN 2019-01-02
Neurotransmitter-gated ion-channel ligand binding domain (100%), Neurotransmitter-gated ion-channel transmembrane region (27%) (view alignment) glra1 (O93430) - ZEBRA FISH 3JAF_C 41.2 1.0E-61 3.8Å NAG IVM 2015-09-09